Publication:
IS THERE ANY DIFFERENCE IN RA PATIENTS FOR METHOTREXATE USE VS. LEFLUNOMIDE USE AS A CONCOMITANT TREATMENT WITH BIOLOGICAL AND TARGETED SYNTHETIC DMARDS IN TURKBIO REGISTRY?

Simple item page
dc.contributor.authorİNANÇ, GÜZİDE NEVSUN
dc.contributor.authorsInanc, N.; Ozen, G.; Yalcinkaya, Y.; Dalkilic, E.; Koca, S. S.; Can, G.; Karatas, A.; Pehlivan, Y.; Yazici, A.; Cefle, A.; Tufan, A.; Akar, S.; Senel, S.; Oz, B.; Akkoc, N.; Onen, F.
dc.date.accessioned2022-03-12T04:15:53Z
dc.date.accessioned2026-01-11T15:50:09Z
dc.date.available2022-03-12T04:15:53Z
dc.date.issued2018-06
dc.identifier.doi10.1136/annrheumdis-2018-eular.5662
dc.identifier.eissn1468-2060
dc.identifier.issn0003-4967
dc.identifier.urihttps://hdl.handle.net/11424/223315
dc.identifier.wosWOS:000444351001597
dc.language.isoeng
dc.publisherBMJ PUBLISHING GROUP
dc.relation.ispartofANNALS OF THE RHEUMATIC DISEASES
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleIS THERE ANY DIFFERENCE IN RA PATIENTS FOR METHOTREXATE USE VS. LEFLUNOMIDE USE AS A CONCOMITANT TREATMENT WITH BIOLOGICAL AND TARGETED SYNTHETIC DMARDS IN TURKBIO REGISTRY?
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPage612
oaire.citation.startPage611
oaire.citation.titleANNALS OF THE RHEUMATIC DISEASES
oaire.citation.volume77

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
file.pdf
Size:
577.53 KB
Format:
Adobe Portable Document Format
Download

Collections

Araştırma Çıktıları